603
Views
12
CrossRef citations to date
0
Altmetric
Review

Recent advances in proteolytic stability for peptide, protein, and antibody drug discovery

, &
Pages 1467-1482 | Received 18 Dec 2020, Accepted 10 Jun 2021, Published online: 30 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Manisha Pritam, Somenath Dutta, Krishna Mohan Medicherla, Rajnish Kumar & Satarudra Prakash Singh. (2023) Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now
Simone Esposito, Laura Orsatti & Vincenzo Pucci. (2022) Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations. Xenobiotica 52:8, pages 828-839.
Read now

Articles from other publishers (10)

D. Cardella, D. Sanchez-Guzman & T.H. Rabbitts. (2023) Intracellular antibodies and biodegraders: Beyond small molecules and back again. Current Opinion in Biomedical Engineering 27, pages 100455.
Crossref
Qinqin Fei, Ian Bentley, Samir N. Ghadiali & Joshua A. Englert. (2023) Pulmonary drug delivery for acute respiratory distress syndrome. Pulmonary Pharmacology & Therapeutics 79, pages 102196.
Crossref
Shikha Patel, Vivek K. Vyas & Priti J. Mehta. (2023) A Review on Forced Degradation Strategies to Establish the Stability of Therapeutic Peptide Formulations. International Journal of Peptide Research and Therapeutics 29:2.
Crossref
Diego José Laderach & Daniel Compagno. (2023) Inhibition of galectins in cancer: Biological challenges for their clinical application. Frontiers in Immunology 13.
Crossref
Armando Rodríguez-Alfonso, Astrid Heck, Yasser Bruno Ruiz-Blanco, Andrea Gilg, Ludger Ständker, Seah Ling Kuan, Tanja Weil, Elsa Sanchez-Garcia, Sebastian Wiese, Jan Münch & Mirja Harms. (2022) Advanced EPI-X4 Derivatives Covalently Bind Human Serum Albumin Resulting in Prolonged Plasma Stability. International Journal of Molecular Sciences 23:23, pages 15029.
Crossref
Abigail N. Smith, Madelaine P. Thorpe, Daniel J. Blackwell, Suzanne M. Batiste, Corey R. Hopkins, Nathan D. Schley, Bjorn C. Knollmann & Jeffrey N. Johnston. (2022) Structure–Activity Relationships for the N -Me- Versus N -H-Amide Modification to Macrocyclic ent -Verticilide Antiarrhythmics . ACS Medicinal Chemistry Letters 13:11, pages 1755-1762.
Crossref
Zhenheng Lai, Xiaojie Yuan, Hongyu Chen, Yunhui Zhu, Na Dong & Anshan Shan. (2022) Strategies employed in the design of antimicrobial peptides with enhanced proteolytic stability. Biotechnology Advances 59, pages 107962.
Crossref
Paulina Gonzalez, Laurent Sabater, Emilie Mathieu, Peter Faller & Christelle Hureau. (2022) Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer’s-Related Aβ Peptide. Biomolecules 12:10, pages 1327.
Crossref
Plinio Alejandro Trinidad-Calderón, Laura Margarita López-Castillo, Salvador Gallegos-Martínez, Grissel Trujillo-de Santiago, Silverio García-Lara & Mario Moisés Álvarez. (2022) nurP28, a New-to-Nature Zein-Derived Peptide, Enhances the Therapeutic Effect of Docetaxel in Breast Cancer Monolayers and Spheroids. Molecules 27:9, pages 2824.
Crossref
Jingyan Pei, Xinchang Gao, Daodong Pan, Ying Hua, Jun He, Zhu Liu & Yali Dang. (2022) Advances in the stability challenges of bioactive peptides and improvement strategies. Current Research in Food Science 5, pages 2162-2170.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.